Duffey, D.C., Chen, Z., Dong, G., Ondrey, F.G., Wolf, J.S., Brown, K., Siebenlist, U. and Van Waes, C. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous celi carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999; 59: 3468-3474.
Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledgc, S.J. and Reed, S.I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Celi 1994; 76: 1013-1023.
Dutta, A., Ruppert, J.M., Aster, J.C. and Winchester, E. Inhibition of DNA replication factor RPA by p53 [see commentsj. Naturę 1993; 365: 79-82.
Dyson, N., Guida, P., Munger, K. and Harlow, E. Homologous sequences in adenovirus El A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins. J Virol 1992; 66: 6893-6902.
Dyson, N., Howley, P.M., Munger, K. and Harlow, E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
el-Deiry, W.S., Harper, J.W., 0'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y. and et al.
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994; 54: 1169-1174.
el-Deiry, W.S., Tokino, T., Velculescu, V.E., Levy, D.B., Parsons, R., Trcnt, J.M., Lin, D., Mercer, W.E., Kinzler, K.W. and VogeIstein, B. WAF1, a potential mediator of p53 tumor suppression. Celi 1993; 75: 817-825.
Epinat, J.C. and Gilmore, T.D. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway. Oncogene 1999; 18: 6896-6909.
Evan, G. and Littlewood, T. A matter of life and celi death. Science 1998; 281: 1317-1322.
Favaudon, V. (Regulation of celi cycle and radiation-induced celi death). Cancer Radiother 2000; 4: 355-368.
Flores-Rozas, H., Kelman, Z., Dean, F.B., Pan, Z.Q., Harper, J.W., Elledge, S.J., 0'Donnell, M. and Hurwitz, J. Cdk-interacting protein 1 directly binds with proiiferating celi nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 1994; 91: 8655-8659.
Frantz, B., Nordby, E.C., Bren, G., Steffan, N., Paya, C.V., Kincaid, R.L., Tocci, M.J., 0'Keefe, S.J. and 0'Neill, E.A. Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B. EmboJ 1994; 13: 861-870.
Frantz, B. and 0'Neill, E.A. The effect of sodium salicylate and aspirin on NF-kappa B. Science 1995; 270: 2017-2019.
Franzoso, G., Bours, V., Azarenko, V., Park, S., Tomita-Yamaguchi, M., Kanno, T., Brown, K. and Siebenlist, U. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transachvation by removing inhibiting p50 homodimers from select kappa B sites. EmboJ 1993; 12: 3893-3901.
Franzoso, G., Bours, V., Park, S., Tomita-Yamaguchi, M., Kelly, K. and Siebenlist, U.
The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition. Naturę 1992; 359: 339-342.
Freedman, D.A. and Levine, A.J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Celi Biol 1998; 18: 7288-7293.
Ftichs, S.Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S.N. and Ronai, Z. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 1998a; 12: 2658-2663.
170